United States Biotechnology & Medical Research

Dimension Therapeutics Inc (DMTX)

Track

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: DMTX Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Dimension Therapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Clark K. Reed SVP of Pharmaceutical Develop Officer

Transaction date 7 Jun 2016

Planned sale

Price

360.32

Quantity 16,344 +26.5%

Value US$1,225,279

Comments Filing

Dybbs Michael Non-Executive Director

Transaction date 27 Oct 2015

Purchase

Price

55.50

Quantity 76,861 -46.2%

Value US$4,091,629

Comments Filing

Gupta Rishi Non-Executive Director Large shareholder

Transaction date 27 Oct 2015

Purchase

Price

330.78

Quantity 26,933 -47.2%

Value US$2,546,449

Comments Filing

ORBIMED ADVISORS LLC Non-Executive Director Large shareholder

Transaction date 27 Oct 2015

Purchase

Price

13.00

Quantity 200,000 +3.8%

Value US$2,600,000

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2016-06-08	2016-06-07	PlS Planned sale	Clark K. Reed SVP of Pharmaceutical Develop Officer	16,344 +26.5% 360.32 US$1,225,279	16,344 +26.5%	360.32	US$1,225,279
2015-10-29	2015-10-27	B Purchase	Dybbs Michael Non-Executive Director	76,861 -46.2% 55.50 US$4,091,629	76,861 -46.2%	55.50	US$4,091,629
2015-10-29	2015-10-27	B Purchase	Gupta Rishi Non-Executive Director Large shareholder	26,933 -47.2% 330.78 US$2,546,449	26,933 -47.2%	330.78	US$2,546,449
2015-10-29	2015-10-27	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	200,000 +3.8% 13.00 US$2,600,000	200,000 +3.8%	13.00	US$2,600,000